patent/WO-2013100672-A1

http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013100672-A1

Outgoing Links

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a82962e22b6ae66d43ee1e8c950d93db http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e5ad8562c578b061df7a2c3aee9d0e24
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-416
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D231-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-416 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate	2012-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ca05db42200941e0293c7d1696fc9c1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_897af7d110f540f46d28b371bc773f0a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ebd0e09e31f6171d79ee70cac733994c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f1994813baaf53253de7167f5387d29a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_12b47a42537600a02b7adae275fa737d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a94870b20c39eac408519515aaa8ec9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8017892d2bb7f5b7367ac72f2fbca1a1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_73bed6e436af52e49893eb4e29db163d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3717c48a2c10620036cb195eb09f3e6a
publicationDate	2013-07-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	WO-2013100672-A1
titleOfInvention	3,6-disubstituted indazole derivative having protein kinase inhibiting activity
abstract	The present invention relates to a novel 3,6-disubstituted indazole derivative or a pharmaceutically acceptable salt thereof, to a production method for same, and to a pharmaceutical composition comprising same as an active ingredient. The pharmaceutical composition of the present invention exhibits an outstanding suppressing effect against protein kinases that induce cancer, such as B-Raf kinase, and can therefore be used to advantage in the prevention or treatment of cancer.
isCitedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7191828-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105473590-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9328096-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11498903-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9790180-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10968180-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11702389-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10358421-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015322043-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016168093-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11034669-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2017512794-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015024905-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107835810-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IL-267247-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3555077-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10239837-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2020514254-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11136297-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9062051-B2
priorityDate	2011-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate	Subject
isCitedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03051847-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101061599-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006003276-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9723480-A1
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9221 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397820 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID229107387

Total number of triples: 54.